GlobalData reports more adults with type 2 diabetes reached both blood sugar and weight goals on tirzepatide than on semaglutide.
Recap by typeshit. Post by Facebook on Facebook.
A Facebook share says Danish teams found certain bacterial strains may change how the gut tells the brain it is full. The work so far is in animal models only.
Bikman calls the results remarkable, but he argues that bigger drops make it more important to know how much of the lost weight is fat and how much is muscle.
Bikman points out that weight usually returns once the drug is stopped, which makes the question of lifelong use a real one.
Avi Roy flags a preprint that pooled 10,052 people from five semaglutide trials and used a blood test to estimate heart age. It has not yet been peer reviewed.
A Harvard and Copenhagen review found 43 percent of users eat too little protein, and a Northwestern study saw deficiencies in nearly one in six teens.
The health committee says the plan to reach 220,000 people would cover only 6% of 2.8 million eligible patients, and suggests using digital providers.
Loading…